Loss of HOPX expression as a result of promoter hypermethylation has clinical significance because in patients with gastric and colorectal cancer, the methylation status has been linked to a worse prognosis [55,61] and patients with strong HOPX expression in lung cancer have a considerably longer survival [56]. The gene discussed is HOPX; the disease is lung cancer.